Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses
GOS displayed prebiotic potential at capsule-compatible doses, offering greater flexibility in nutritional product formulation and consumer convenience. Notably, the strong response at the lowest dose suggests effective microbiome modulation at lower levels than previously expected.
Authors
- Aurélien Baudot (ORCID: https://orcid.org/0009-0009-4872-6875)
- Ingmar A. J. van Hengel (ORCID: https://orcid.org/0000-0002-7171-257X)
- J. Heyse (ORCID: https://orcid.org/0000-0002-8858-9803)
- Lucien F. Harthoorn
- Pieter Van den Abbeele (ORCID: https://orcid.org/0000-0002-1399-6332)
Institutions
- Clasado BioSciences (United Kingdom) (GB)
Publication Details
- Journal
- Metabolites
- Published
- 2025-08-05
- DOI
- https://doi.org/10.3390/metabo15080530
- Citations
- 2
- Primary Topic
- Chemical Reactions and Isotopes
- Type
- article
- Field-Weighted Citation Impact
- 1.58